Stock of the Day

August 5, 2019

IDEXX Laboratories (IDXX)

$452.77
-$0.09 (-0.0%)
Market Cap: $37.08B

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories Bull Case

Here are some ways that investors could benefit from investing in IDEXX Laboratories, Inc.:

  • The current stock price is $444.53, which reflects a significant trading volume and market interest, indicating potential for growth.
  • IDEXX Laboratories, Inc. has a strong market capitalization of $36.40 billion, suggesting stability and a solid position in the market.
  • Recent analyst ratings show a consensus target price of $533.75, indicating that many analysts believe the stock has room to grow from its current price.
  • The company has a low debt-to-equity ratio of 0.28, which means it is less reliant on borrowed funds, reducing financial risk for investors.
  • Insider trading activity shows confidence in the company, with executives recently selling shares but still retaining significant ownership, indicating they believe in the company's future prospects.

IDEXX Laboratories Bear Case

Investors should be bearish about investing in IDEXX Laboratories, Inc. for these reasons:

  • Insider sales have totaled 13,330 shares worth $6,161,276 in the last three months, which could signal a lack of confidence in the stock's short-term performance.
  • The stock has experienced a recent decline, trading down $15.23 in a single day, which may indicate volatility and potential risks for investors.
  • The company has a relatively high P/E ratio of 41.66, suggesting that the stock may be overvalued compared to its earnings, which could deter value-focused investors.
  • Analysts have mixed ratings, with some downgrading their price targets, which could create uncertainty about the stock's future performance.
  • The company operates in competitive markets, including veterinary and water testing, which may pose challenges in maintaining market share and profitability.

Recent News